| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/14/2005 | US6905885 Portable pathogen detection system |
| 06/14/2005 | US6905884 Fluorescent cobalamins and uses thereof |
| 06/14/2005 | US6905882 Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| 06/14/2005 | US6905880 Bilirubin tests as risk predictors for systemic lupus erythematosus and psoriatic arthritis |
| 06/14/2005 | US6905879 Accurate measurement mof proteins in sample; obtain sample, reduce sulfide bonds, label proteins and peptides, separate proteins and peptides from sample, digest protein mixture, quantitfy and map proteins |
| 06/14/2005 | US6905874 Contacting T-cells with a surface that has attached thereto one or more agents that ligate a cell surface moiety and applying a force that drives cell concentration and cell surface moiety ligation |
| 06/14/2005 | US6905866 Sigma binding region of RNA polymerase and uses thereof |
| 06/14/2005 | US6905855 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/14/2005 | US6905847 Method of increasing product expression through solute stress |
| 06/14/2005 | US6905845 Isolated nucleic acids; allergies sensitivity |
| 06/14/2005 | US6905844 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/14/2005 | US6905842 Modulation signal transduction; isolated nucleic acids; genetic engineering |
| 06/14/2005 | US6905838 In bioreactor; using light source; imaging cells, calibration intensity |
| 06/14/2005 | US6905835 Assay for anti transglutaminase antibodies detection useful in celicac disease diagnosis |
| 06/14/2005 | US6905833 Method of diagnosing breast cancer using nipple fluid |
| 06/14/2005 | US6905831 Real time measurement of cellular responses |
| 06/14/2005 | US6905830 Tissue analysis and kits therefor |
| 06/14/2005 | US6905829 Method for detecting hybridized nucleic acid with improved sensitivity |
| 06/14/2005 | US6905828 Signaling compound for use as diagnostic tools in chromosome analysis |
| 06/14/2005 | US6905823 Cellular arrays and methods of detecting and using genetic disorder markers |
| 06/14/2005 | US6905820 Polyamide nucleic acid derivatives, and agents and processes for preparing them |
| 06/14/2005 | US6905818 Detection cloning; isolation hybrids; using labels; genetic engineering |
| 06/14/2005 | US6905817 Screening signal antagonist; glial cell neutrotropic factor; therapy for nervous system disorders |
| 06/14/2005 | US6905816 Designing microarrays to accurately detect and diagnosis infectious and/or genetic disorders; drug screening |
| 06/14/2005 | US6905815 Identifying modulators of valosin-containing protein (VCP) binding activity for treatment and prevention of neurodegenerative and nervous system disorders |
| 06/14/2005 | US6905766 Encapsulation of discrete quanta of fluorescent particles |
| 06/14/2005 | US6905689 Suitable as a standard for the determination of alkaline phosphatase. |
| 06/14/2005 | US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents |
| 06/14/2005 | US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents |
| 06/14/2005 | US6905670 Exposing eukaryotic organisms to a single fungal pathogen in the presence of at least one candidate compound; identifying a compound that inhibits fungal pathogen in each of eukaryotic organisms |
| 06/14/2005 | US6905655 For electronic detection of chemical and biological materials |
| 06/14/2005 | US6905653 Polymer beads embedded with light reflecting particles; carbon black light blocking compound |
| 06/14/2005 | US6905612 Plasma concentrate apparatus and method |
| 06/14/2005 | US6905453 System and method for centrifugal separating of blood components and for sampling therefrom |
| 06/14/2005 | US6904865 Wetness indicator having improved colorant retention and durability |
| 06/14/2005 | CA2264585C Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions |
| 06/14/2005 | CA2186945C Method for processing mycobacteria |
| 06/14/2005 | CA2149508C Method and apparatus for assessing the viability of plant material |
| 06/14/2005 | CA2138622C Reagent for analyzing leucocytes |
| 06/12/2005 | CA2489915A1 Method of assessing skin and overall health of an individual |
| 06/10/2005 | CA2489266A1 Reagents for detecting efavirenz |
| 06/09/2005 | WO2005052596A1 A reference solution |
| 06/09/2005 | WO2005052595A1 Method for diagnosing the functional state of a bioobject |
| 06/09/2005 | WO2005052594A1 Method of examining blood type and apparatus for examining blood type using the method. |
| 06/09/2005 | WO2005052593A1 Detection |
| 06/09/2005 | WO2005052592A2 Methods for diagnosis, stratification, and monitoring of alzheimer’s disease |
| 06/09/2005 | WO2005052591A1 Methods and device for analyte characterization |
| 06/09/2005 | WO2005052590A1 High-throughput screening method for integrin antagonist and new peptide screened therefrom |
| 06/09/2005 | WO2005052589A1 Method for quantitative and semi-quantitative detection of l-phenylalanine, l-tyrosine, l-3, 4-dihydroxyphenylalanine and their corresponding keto-acids |
| 06/09/2005 | WO2005052588A2 Detection of protein interactions |
| 06/09/2005 | WO2005052587A2 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 7 (kcnk7) |
| 06/09/2005 | WO2005052586A2 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3) |
| 06/09/2005 | WO2005052585A1 Method for the detection of pathologically modified prion proteins (prpsc) |
| 06/09/2005 | WO2005052584A1 Method of immobilizing a substance of interest to a solid phase |
| 06/09/2005 | WO2005052583A1 Method of detecting substance to be analyzed |
| 06/09/2005 | WO2005052582A2 Methods and apparatus for cell based microarray assays |
| 06/09/2005 | WO2005052581A2 Spherical and magnetic silicagel carriers having an increase surface for purifying nucleic acids |
| 06/09/2005 | WO2005052580A1 Photolinker macromolecules, metallic substrates and ligands modified with said linkers, and process of preparation thereof |
| 06/09/2005 | WO2005052579A1 Knsls as modifiers of the apc and axin pathways and methods of use |
| 06/09/2005 | WO2005052577A1 Method to identify a biomolecular profile |
| 06/09/2005 | WO2005052576A1 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 6 (kcnk6) |
| 06/09/2005 | WO2005052575A1 Molecular markers of oxidative stress |
| 06/09/2005 | WO2005052574A2 Diagnostics and therapeutics for diseases associated with potassium channel subfamily k, member 4 (kcnk4) |
| 06/09/2005 | WO2005052573A1 Fluid monitoring apparatus and method |
| 06/09/2005 | WO2005052571A2 System for the generation of a reference gas by the evaporation of a liquid in said gas |
| 06/09/2005 | WO2005052567A1 Methods for detecting half-antibodies using chip-based gel electrophoresis |
| 06/09/2005 | WO2005052566A2 Gas sensor device |
| 06/09/2005 | WO2005052565A1 Fluid condition monitoring using broad spectrum impendance spectroscopy |
| 06/09/2005 | WO2005052563A1 Peptide derivatization for enhancing protein identification by mass spectrometry |
| 06/09/2005 | WO2005052561A1 Hydrometric measurement transmitter and assembly |
| 06/09/2005 | WO2005052559A1 Method of identifying pigments from a single cell using confocal image spectrophotometry in phototrophic communities |
| 06/09/2005 | WO2005052555A1 Method for determining the gas permeability of container walls, container provided with a surface coating, and coating device comprising a measuring element |
| 06/09/2005 | WO2005052548A2 Method for adjusting the quantification range of individual analytes in a multiplexed assay |
| 06/09/2005 | WO2005052542A2 Method and composition useful for determining fk 506 |
| 06/09/2005 | WO2005052541A2 Method of separation and collection and apparatus therefor |
| 06/09/2005 | WO2005052539A1 Measuring device, preferably a test stand for engines and vehicles for analyzing exhaust gases of a combustion engine |
| 06/09/2005 | WO2005052192A1 Pancreatitis |
| 06/09/2005 | WO2005052190A1 MARKER Lmx1a SPECIFIC TO DOPAMINE-PRODUCING NEURON |
| 06/09/2005 | WO2005052187A1 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 06/09/2005 | WO2005052186A1 Means and methods for the determination of camp in vitro and in vivo |
| 06/09/2005 | WO2005052184A1 Use of isogenic drug-resistant cell lines to determine the sequence of chemotherapeutic drug treatment |
| 06/09/2005 | WO2005052183A1 Method and composition for stabilizing liquid reagents |
| 06/09/2005 | WO2005052182A2 A method of analyzing plasma membrane protein content of cells |
| 06/09/2005 | WO2005052157A1 Il-23 and its receptor; related reagents and methods |
| 06/09/2005 | WO2005052156A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 06/09/2005 | WO2005052154A1 Method of estimating toxicity of drug |
| 06/09/2005 | WO2005052150A1 Method of controlling transcription of insulin gene |
| 06/09/2005 | WO2005052139A2 Method of inducing memory b cell development and terminal differentiation |
| 06/09/2005 | WO2005052134A2 Ttbks as modifiers of the beta catenin pathway and methods of use |
| 06/09/2005 | WO2005052132A2 Mbms as modifiers of branching morphogenesis and methods of use |
| 06/09/2005 | WO2005052131A2 C140rf35 as modifier of the beta catenin pathway and methods of use |
| 06/09/2005 | WO2005052130A2 Nrbps as modifiers of the rac pathway and methods of use |
| 06/09/2005 | WO2005052125A2 24p3 receptors and uses thereof |
| 06/09/2005 | WO2005052118A2 Method for identifying androgen receptor modulators with full or mixed agonist activity |
| 06/09/2005 | WO2005052115A2 Use of parasitic biological agents for diseases prevention and control |
| 06/09/2005 | WO2005051995A2 Novel advanced glycosylation end product-specific receptor-like protein and nucleic acids encoding same |
| 06/09/2005 | WO2005051990A2 Polynucleotides overexpressed in breast cancer cells, compositions and methods for the therapy and diagnosis of breast cancer |
| 06/09/2005 | WO2005051985A2 Methods for purifying pertussis toxin and peptides useful therefor |
| 06/09/2005 | WO2005051977A2 Conditional allele system |
| 06/09/2005 | WO2005051956A1 Brevetoxin derivative, process for producing the same and method of detecting shellfish neurotoxin using the same |